Antiparkinsonian therapy.
Powerful new tools for the treatment of parkinsonism include levodopa, decarboxylase inhibitors, and dopaminergic agonists. Yet earlier drugs still have a useful role to play. The decision to begin pharmacotherapy must be adjusted individually for each patient.